• Je něco špatně v tomto záznamu ?

Promoting Prevention and Targeting Remission of Asthma: A EUFOREA Consensus Statement on Raising the Bar in Asthma Care

M. Jesenak, A. Bobcakova, R. Djukanovic, M. Gaga, NA. Hanania, LG. Heaney, I. Pavord, S. Quirce, D. Ryan, W. Fokkens, D. Conti, PW. Hellings, G. Scadding, E. Van Staeyen, LH. Bjermer, Z. Diamant

. 2025 ; 167 (4) : 956-974. [pub] 20241211

Jazyk angličtina

Typ dokumentu konsensus - konference, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25016300

Asthma is a common, multifaceted respiratory disease with a major impact on quality of life. Despite increased insights into mechanisms underlying various asthma phenotypes and endotypes and the availability of targeted biologic treatment options, the disease remains uncontrolled in a substantial proportion of patients with risk of exacerbations, requiring systemic corticosteroids, and with progressive disease. Current international guidelines advocate for a personalized management approach to patients with uncontrolled severe asthma. The European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) asthma expert panel was convened to discuss strategies to optimize asthma care and to prevent systemic corticosteroid overuse and disease progression. In this meeting report, we summarize current concepts and recommendations and provide a rationale to implement personalized asthma management at earlier stages of the disease. The ultimate goal is to move away from the current one-size-fits-most concept, which focuses on a symptom-driven treatment strategy, and shift toward a phenotype- and endotype-targeted approach aimed at curbing the disease course by improving clinical outcomes and preserving health-related quality of life. Herein, we provide a consensus view on asthma care that advocates a holistic approach and highlight some unmet needs to be addressed in future clinical trials and population studies.

1st Respiratory Medicine Dept Hygeia Hospital Athens Greece

AUKCAR Usher Institute University of Edinburgh Edinburgh United Kingdom

Department of Allergy La Paz University Hospital IdiPAZ CIBER of Respiratory Diseases Madrid Spain

Department of Microbiology Immunology and Transplantation KU Leuven Catholic University of Leuven Leuven Belgium

Department of Otorhinolaryngology Amsterdam University Medical Centres Amsterdam the Netherlands

Department of Otorhinolaryngology University of Leuven Leuven Belgium

Department of Pediatrics Jessenius Faculty of Medicine in Martin Comenius University in Bratislava University Teaching Hospital in Martin Martin Slovakia

Department of Pulmonology and Phthisiology Jessenius Faculty of Medicine in Martin Comenius University in Bratislava University Teaching Hospital in Martin Martin Slovakia

Department of Respiratory Medicine 1st Faculty of Medicine Charles University and Thomayer Hospital Prague Czech Republic

Department of Respiratory Medicine and Allergology Institute for Clinical Science Skane University Hospital Lund University Lund Sweden

Division of Infection and Immunity University College London United Kingdom

Escuela de Doctorado UAM Centro de Estudios de Posgrado Universidad Autónoma de Madrid Calle Francisco Tomás y Valiente no 2 Ciudad Universitaria de Cantoblanco Madrid Spain

Institute of Clinical Immunology and Medical Genetics Jessenius Faculty of Medicine in Martin Comenius University in Bratislava University Teaching Hospital in Martin Martin Slovakia

Laboratory of Allergy and Clinical Immunology University of Leuven Leuven Belgium

NIHR Oxford Biomedical Research Centre Nuffield Department of Medicine University of Oxford Oxford United Kingdom

NIHR Southampton Biomedical Centre Faculty of Medicine University of Southampton United Kingdom

Section of Pulmonary and Critical Care Medicine Baylor College of Medicine Houston TX

The European Forum for Research and Education in Allergy and Airway Diseases Scientific Expert Team Members Brussels Belgium

The Royal National ENT Hospital London United Kingdom

University of Groningen University Medical Center Groningen Department of Clinical Pharmacy and Pharmacology Groningen the Netherlands

Upper Airways Disease Laboratory University of Ghent Ghent Belgium

Wellcome Wolfson Institute for Experimental Medicine Queen's University Belfast Belfast United Kingdom

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25016300
003      
CZ-PrNML
005      
20250731092810.0
007      
ta
008      
250708s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.chest.2024.11.035 $2 doi
035    __
$a (PubMed)39672229
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a x
100    1_
$a Jesenak, Milos $u Department of Pediatrics, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Teaching Hospital in Martin, Martin, Slovakia; Department of Pulmonology and Phthisiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Teaching Hospital in Martin, Martin, Slovakia; Institute of Clinical Immunology and Medical Genetics, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Teaching Hospital in Martin, Martin, Slovakia
245    10
$a Promoting Prevention and Targeting Remission of Asthma: A EUFOREA Consensus Statement on Raising the Bar in Asthma Care / $c M. Jesenak, A. Bobcakova, R. Djukanovic, M. Gaga, NA. Hanania, LG. Heaney, I. Pavord, S. Quirce, D. Ryan, W. Fokkens, D. Conti, PW. Hellings, G. Scadding, E. Van Staeyen, LH. Bjermer, Z. Diamant
520    9_
$a Asthma is a common, multifaceted respiratory disease with a major impact on quality of life. Despite increased insights into mechanisms underlying various asthma phenotypes and endotypes and the availability of targeted biologic treatment options, the disease remains uncontrolled in a substantial proportion of patients with risk of exacerbations, requiring systemic corticosteroids, and with progressive disease. Current international guidelines advocate for a personalized management approach to patients with uncontrolled severe asthma. The European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) asthma expert panel was convened to discuss strategies to optimize asthma care and to prevent systemic corticosteroid overuse and disease progression. In this meeting report, we summarize current concepts and recommendations and provide a rationale to implement personalized asthma management at earlier stages of the disease. The ultimate goal is to move away from the current one-size-fits-most concept, which focuses on a symptom-driven treatment strategy, and shift toward a phenotype- and endotype-targeted approach aimed at curbing the disease course by improving clinical outcomes and preserving health-related quality of life. Herein, we provide a consensus view on asthma care that advocates a holistic approach and highlight some unmet needs to be addressed in future clinical trials and population studies.
650    _2
$a lidé $7 D006801
650    12
$a antiastmatika $x terapeutické užití $7 D018927
650    12
$a bronchiální astma $x prevence a kontrola $x terapie $x farmakoterapie $7 D001249
650    _2
$a konsensus $7 D032921
650    _2
$a management nemoci $7 D019468
650    _2
$a progrese nemoci $7 D018450
650    _2
$a individualizovaná medicína $7 D057285
650    _2
$a kvalita života $7 D011788
650    _2
$a indukce remise $7 D012074
655    _2
$a konsensus - konference $7 D016446
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bobcakova, Anna $u Department of Pediatrics, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Teaching Hospital in Martin, Martin, Slovakia; Department of Pulmonology and Phthisiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Teaching Hospital in Martin, Martin, Slovakia; Institute of Clinical Immunology and Medical Genetics, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Teaching Hospital in Martin, Martin, Slovakia
700    1_
$a Djukanovic, Ratko $u NIHR Southampton Biomedical Centre, Faculty of Medicine, University of Southampton, United Kingdom
700    1_
$a Gaga, Mina $u 1st Respiratory Medicine Dept., Hygeia Hospital, Athens, Greece
700    1_
$a Hanania, Nicola A $u Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX
700    1_
$a Heaney, Liam G $u Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom
700    1_
$a Pavord, Ian $u NIHR Oxford Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
700    1_
$a Quirce, Santiago $u Department of Allergy, La Paz University Hospital, IdiPAZ, CIBER of Respiratory Diseases (CIBERES), Madrid, Spain
700    1_
$a Ryan, Dermot $u AUKCAR, Usher Institute, University of Edinburgh, Edinburgh, United Kingdom
700    1_
$a Fokkens, Wytske $u Department of Otorhinolaryngology, Amsterdam University Medical Centres, Amsterdam, the Netherlands
700    1_
$a Conti, Diego $u The European Forum for Research and Education in Allergy and Airway Diseases Scientific Expert Team Members, Brussels, Belgium; Escuela de Doctorado UAM, Centro de Estudios de Posgrado, Universidad Autónoma de Madrid. Calle Francisco Tomás y Valiente, no 2. Ciudad Universitaria de Cantoblanco, Madrid, Spain
700    1_
$a Hellings, Peter W $u Department of Otorhinolaryngology, University of Leuven, Leuven, Belgium; Laboratory of Allergy and Clinical Immunology, University of Leuven, Leuven, Belgium; Upper Airways Disease Laboratory, University of Ghent, Ghent, Belgium
700    1_
$a Scadding, Glenis $u The Royal National ENT Hospital, London, United Kingdom; Division of Infection and Immunity, University College, London, United Kingdom
700    1_
$a Van Staeyen, Elizabeth $u The European Forum for Research and Education in Allergy and Airway Diseases Scientific Expert Team Members, Brussels, Belgium
700    1_
$a Bjermer, Leif H $u Department of Respiratory Medicine & Allergology, Institute for Clinical Science, Skane University Hospital, Lund University, Lund, Sweden
700    1_
$a Diamant, Zuzana $u University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy & Pharmacology, Groningen, the Netherlands; Department of Microbiology Immunology & Transplantation, KU Leuven, Catholic University of Leuven, Leuven, Belgium; Department of Respiratory Medicine, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic. Electronic address: z.diamant@4gems.nl
773    0_
$w MED00002127 $t Chest $x 1931-3543 $g Roč. 167, č. 4 (2025), s. 956-974
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39672229 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250708 $b ABA008
991    __
$a 20250731092804 $b ABA008
999    __
$a ok $b bmc $g 2366862 $s 1253425
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 167 $c 4 $d 956-974 $e 20241211 $i 1931-3543 $m Chest $n Chest $x MED00002127
LZP    __
$a Pubmed-20250708

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...